Assent's EU Medical Device Regulation Module is regularly updated, reflecting changes made to the European Union Medical Device Regulation substance list. The substance list module updates, starting from December 2018, may be useful to Assent clients and their suppliers, as they navigate changes during the reporting cycle.
Substances added during the Dec. 2018 – May 2020 module update cycle:
|
Substance |
CAS Number |
|
1-vinylimidazole |
1072-63-5 |
|
2-benzyl-2-dimethylamino-4-morpholinobutyrophenone |
119313-12-1 |
|
Acetaldehyde |
75-07-0 |
|
butyl 4-hydroxybenzoate |
94-26-8 |
|
Catechol |
120-80-9 |
|
Cobalt(II) diacetate |
71-48-7 |
|
Fluazifop-butyl (not stereo-specific) |
69806-50-4 |
|
Gasoline, natural |
8006-61-9 |
|
Octabromobiphenyl ether |
32536-52-0 |
|
Propiconazole |
60207-90-1 |
Substances added during the May 2020 – Sep. 2021 module update cycle:
|
Substance |
CAS Number |
|
Cobalt |
7440-48-4 |
|
Chloromethylmercury |
115-09-3 |
|
Dibenzo[a,i]pyrene |
189-55-9 |
|
Dibenzo[a,h]pyrene |
189-64-0 |
|
Ethanol, 2,2'-iminobis-, N-(C13-15-branched and linear alkyl) derivs. |
97925-95-6 |
|
Quizalofop-P-tefuryl |
200509-41-7 |
|
Diisohexyl phthalate |
71850-09-4 |
|
Halosulfuron-methyl |
100784-20-1 |
|
2-Methylimidazole |
693-98-1 |
Article is current as of 2020-11-02.
Comments